Catheter Ablation of Atrial Fibrillation With and Without On-Site Cardiothoracic Surgery

Daniel J. Friedman; Sean D. Pokorney; Rahul Khanna; Laura Goldstein; Brett D. Atwater; Tristram D. Bahnson; James P. Daubert; Kevin P. Jackson; E. Kevin Heist; Jagmeet P. Singh; Hugh Calkins; Jonathan P. Piccini

doi:10.1016/j.jacc.2019.02.036

Catheter Ablation of Atrial Fibrillation With and Without On-Site Cardiothoracic Surgery

Daniel J. Friedman, Sean D. Pokorney, Rahul Khanna, Laura Goldstein, Brett D. Atwater, Tristram D. Bahnson, James P. Daubert, Kevin P. Jackson, E. Kevin Heist, Jagmeet P. Singh, Hugh Calkins, Jonathan P. Piccini

School of Medicine

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	2487-2489
Number of pages	3
Journal	Journal of the American College of Cardiology
Volume	73
Issue number	19
DOIs	https://doi.org/10.1016/j.jacc.2019.02.036
State	Published - May 21 2019

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.jacc.2019.02.036

Cite this

Friedman, D. J., Pokorney, S. D., Khanna, R., Goldstein, L., Atwater, B. D., Bahnson, T. D., Daubert, J. P., Jackson, K. P., Heist, E. K., Singh, J. P., Calkins, H., & Piccini, J. P. (2019). Catheter Ablation of Atrial Fibrillation With and Without On-Site Cardiothoracic Surgery. Journal of the American College of Cardiology, 73(19), 2487-2489. https://doi.org/10.1016/j.jacc.2019.02.036

Catheter Ablation of Atrial Fibrillation With and Without On-Site Cardiothoracic Surgery. / Friedman, Daniel J.; Pokorney, Sean D.; Khanna, Rahul; Goldstein, Laura; Atwater, Brett D.; Bahnson, Tristram D.; Daubert, James P.; Jackson, Kevin P.; Heist, E. Kevin; Singh, Jagmeet P.; Calkins, Hugh; Piccini, Jonathan P.

In: Journal of the American College of Cardiology, Vol. 73, No. 19, 21.05.2019, p. 2487-2489.

Research output: Contribution to journal › Letter › peer-review

Friedman, DJ, Pokorney, SD, Khanna, R, Goldstein, L, Atwater, BD, Bahnson, TD, Daubert, JP, Jackson, KP, Heist, EK, Singh, JP, Calkins, H & Piccini, JP 2019, 'Catheter Ablation of Atrial Fibrillation With and Without On-Site Cardiothoracic Surgery', Journal of the American College of Cardiology, vol. 73, no. 19, pp. 2487-2489. https://doi.org/10.1016/j.jacc.2019.02.036

Friedman, Daniel J. ; Pokorney, Sean D. ; Khanna, Rahul ; Goldstein, Laura ; Atwater, Brett D. ; Bahnson, Tristram D. ; Daubert, James P. ; Jackson, Kevin P. ; Heist, E. Kevin ; Singh, Jagmeet P. ; Calkins, Hugh ; Piccini, Jonathan P. / Catheter Ablation of Atrial Fibrillation With and Without On-Site Cardiothoracic Surgery. In: Journal of the American College of Cardiology. 2019 ; Vol. 73, No. 19. pp. 2487-2489.

@article{8e2b8d451e4246c1b7d8b9461b49d62f,

title = "Catheter Ablation of Atrial Fibrillation With and Without On-Site Cardiothoracic Surgery",

author = "Friedman, {Daniel J.} and Pokorney, {Sean D.} and Rahul Khanna and Laura Goldstein and Atwater, {Brett D.} and Bahnson, {Tristram D.} and Daubert, {James P.} and Jackson, {Kevin P.} and Heist, {E. Kevin} and Singh, {Jagmeet P.} and Hugh Calkins and Piccini, {Jonathan P.}",

note = "Funding Information: Please note: Funding for this analysis was provided by Johnson and Johnson. Dr. Friedman has received salary support from the National Institutes of Health; research support from the National Cardiovascular Data Registry, Boston Scientific, Biosense Webster, and Abbott; and educational grants from Boston Scientific, Medtronic, Abbott, and Biotronik. Dr. Pokorney has received research grants from Boston Scientific, Janssen Pharmaceuticals, Bristol-Myers Squibb, Pfizer, and Gilead; and has received consulting/advisory board support from Boston Scientific, Medtronic, Janssen Pharmaceuticals, Bristol-Myers Squibb, Pfizer, and Portola. Dr. Khanna is an employee of Johnson & Johnson. Dr. Goldstein is employed by Biosense Webster, Johnson & Johnson Medical Devices Companies; and owns Johnson & Johnson stock. Dr. Atwater has received research funding from Abbott and Boston Scientific; has served on advisory boards for Abbott, Biotronik, and Medtronic; has served as a consultant for Abbott and Biosense Webster; and has served as a speaker for Medtronic. Dr. Bahnson has received research grants from Abbott, CardioFocus, the National Institutes of Health, and Boston Scientific; has served as a consultant for CardioFocus and Ventrix; is a named investigator on institutional clinical research grant support from Biosense Webster, Boston Scientific, and St. Jude Medical; and has performed case proctoring for CardioFocus Inc. Dr. Daubert has received honoraria for advisory board, data safety monitoring board, consulting, and/or lectures from the American College of Cardiology, ARCA Biopharma, Biosense Webster, Biotronik, Boston Scientific, Farapulse, Gilead, Medtronic, St. Jude, VytronUS, Iowa Approach, Liva Nova, and Zoll; and has received research grants from ARCA biopharma, Biosense Webster, Boston Scientific, Gilead, Medtronic, St. Jude, and the National Institutes of Health, National Heart, Lung, and Blood Institute. Dr. Jackson has received speaker fees from Bristol-Myers Squibb; and has served on the advisory board for Medtronic. Dr. Heist has received research grants from Biotronik, Boston Scientific, EP Dynamics, Biosense Webster, Abbott, Pfizer, and Medtronic; and has served as a consultant for Biosense Webster, Abbott, Medtronic, Pfizer, Boston Scientific, and EP Dynamics. Dr. Singh has received research grants from Abbott and Boston Scientific; and has received consulting fees from Biotronik, Boston Scientific, Medtronic, Liva Nova, Abbott, EBR, Impulse Dynamics, and Toray. Dr. Calkins has served as a consultant for Medtronic, Biosense Webster, and Abbott Medical; and has received lecture honoraria from Medtronic, Biosense Webster, Boehringer Ingelheim, and Abbott Medical. Dr. Piccini has received grants from ARCA biopharma, Abbott, Gilead, Boston Scientific, and Johnson & Johnson; and has received consulting fees from Sanofi, Bayer, Janssen, Allergan, Medtronic, and Philips. The authors wish to acknowledge Drs. Iftekhar Kalsekar and Katherine Etter (Johnson & Johnson) for their valuable assistance with statistical analyses. Neither Dr. Kalsekar nor Dr. Etter received compensation for their contributions, apart from their employment at Johnson & Johnson.",

year = "2019",

month = may,

day = "21",

doi = "10.1016/j.jacc.2019.02.036",

language = "English (US)",

volume = "73",

pages = "2487--2489",

journal = "Journal of the American College of Cardiology",

issn = "0735-1097",

publisher = "Elsevier USA",

number = "19",

}

TY - JOUR

T1 - Catheter Ablation of Atrial Fibrillation With and Without On-Site Cardiothoracic Surgery

AU - Friedman, Daniel J.

AU - Pokorney, Sean D.

AU - Khanna, Rahul

AU - Goldstein, Laura

AU - Atwater, Brett D.

AU - Bahnson, Tristram D.

AU - Daubert, James P.

AU - Jackson, Kevin P.

AU - Heist, E. Kevin

AU - Singh, Jagmeet P.

AU - Calkins, Hugh

AU - Piccini, Jonathan P.

N1 - Funding Information: Please note: Funding for this analysis was provided by Johnson and Johnson. Dr. Friedman has received salary support from the National Institutes of Health; research support from the National Cardiovascular Data Registry, Boston Scientific, Biosense Webster, and Abbott; and educational grants from Boston Scientific, Medtronic, Abbott, and Biotronik. Dr. Pokorney has received research grants from Boston Scientific, Janssen Pharmaceuticals, Bristol-Myers Squibb, Pfizer, and Gilead; and has received consulting/advisory board support from Boston Scientific, Medtronic, Janssen Pharmaceuticals, Bristol-Myers Squibb, Pfizer, and Portola. Dr. Khanna is an employee of Johnson & Johnson. Dr. Goldstein is employed by Biosense Webster, Johnson & Johnson Medical Devices Companies; and owns Johnson & Johnson stock. Dr. Atwater has received research funding from Abbott and Boston Scientific; has served on advisory boards for Abbott, Biotronik, and Medtronic; has served as a consultant for Abbott and Biosense Webster; and has served as a speaker for Medtronic. Dr. Bahnson has received research grants from Abbott, CardioFocus, the National Institutes of Health, and Boston Scientific; has served as a consultant for CardioFocus and Ventrix; is a named investigator on institutional clinical research grant support from Biosense Webster, Boston Scientific, and St. Jude Medical; and has performed case proctoring for CardioFocus Inc. Dr. Daubert has received honoraria for advisory board, data safety monitoring board, consulting, and/or lectures from the American College of Cardiology, ARCA Biopharma, Biosense Webster, Biotronik, Boston Scientific, Farapulse, Gilead, Medtronic, St. Jude, VytronUS, Iowa Approach, Liva Nova, and Zoll; and has received research grants from ARCA biopharma, Biosense Webster, Boston Scientific, Gilead, Medtronic, St. Jude, and the National Institutes of Health, National Heart, Lung, and Blood Institute. Dr. Jackson has received speaker fees from Bristol-Myers Squibb; and has served on the advisory board for Medtronic. Dr. Heist has received research grants from Biotronik, Boston Scientific, EP Dynamics, Biosense Webster, Abbott, Pfizer, and Medtronic; and has served as a consultant for Biosense Webster, Abbott, Medtronic, Pfizer, Boston Scientific, and EP Dynamics. Dr. Singh has received research grants from Abbott and Boston Scientific; and has received consulting fees from Biotronik, Boston Scientific, Medtronic, Liva Nova, Abbott, EBR, Impulse Dynamics, and Toray. Dr. Calkins has served as a consultant for Medtronic, Biosense Webster, and Abbott Medical; and has received lecture honoraria from Medtronic, Biosense Webster, Boehringer Ingelheim, and Abbott Medical. Dr. Piccini has received grants from ARCA biopharma, Abbott, Gilead, Boston Scientific, and Johnson & Johnson; and has received consulting fees from Sanofi, Bayer, Janssen, Allergan, Medtronic, and Philips. The authors wish to acknowledge Drs. Iftekhar Kalsekar and Katherine Etter (Johnson & Johnson) for their valuable assistance with statistical analyses. Neither Dr. Kalsekar nor Dr. Etter received compensation for their contributions, apart from their employment at Johnson & Johnson.

PY - 2019/5/21

Y1 - 2019/5/21

UR - http://www.scopus.com/inward/record.url?scp=85065499839&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065499839&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2019.02.036

DO - 10.1016/j.jacc.2019.02.036

M3 - Letter

C2 - 31076234

AN - SCOPUS:85065499839

VL - 73

SP - 2487

EP - 2489

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 19

ER -